 |
|
|
| |
PHARMACOKINETICS OF FALDAPREVIR AND ANTIRETROVIRALS
IN PATIENTS WITH HIV/HCV CO-INFECTION
|
| |
| |
Reported by Jules Levin
CROI 2014 March 3-6 Boston, MA
Jurgen K Rockstroh1, Marc-Antoine Valantin2, Josep Mallolas3, Massimo Puoti4, Juan A Pineda5, Patrick Ingiliz6, Fenglei Huang7, Richard Vinisko7, Douglas Dieterich8
1University of Bonn, Bonn, Germany; 2Hopital Pitie-Salpetriere, Paris, France; 3Hospital Clinic-University of Barcelona, Barcelona, Spain; 4AO Ospedale Niguarda Ca' Granda Milano, Milan, Italy; 5Hospital Universitario de Valme, Seville, Spain; 6Medical Center for Infectious Diseases, Berlin, Germany; 7Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, USA; 8Mount Sinai Medical Center, New York, NY, USA
|
| |
|
|
|
|
|
